- 2022 - 2027 高齢前立腺癌患者に対する医療の最適化のための医療費および予後予測法の開発
- 2021 - 2024 人工合成糖脂質で惹起される抗腫瘍免疫機序の解明と新規製剤の開発
- 2018 - 2022 抗酸菌表層糖脂質をリード化合物とする新規癌免疫治療法の開発
- 2017 - 2020 土壌抗酸菌細胞壁成分の糖脂質によるアジュバント製剤の開発
- 2016 - 2019 Elucidation of BCG resistance mechanism by comprehensive analysis of immune environment and gene mutation in bladder cancer
- 2014 - 2018 Clarification of the tumor microenvironment in the development of urothelial carcinoma using animal model
- 2014 - 2017 The roles of RAC2-VAV1 signaling in oncogenesis and sarcomatoid differentiation of renal cell carcinoma
- 2014 - 2017 Antitumor effect of liposome incorporating mycolic acid of Mycobacterium bovis bacillus Calmette-Guérin in mouse model.
- 2012 - 2015 Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor
- 2012 - 2015 Efficacy and toxicity of systemic transduction of p16 antitumor peptide in inhibition of metastases of urological tumors
- 2012 - 2014 Development of new cancer therapeutic formulation with BCG mycolic acid
- 2011 - 2013 Treatment of metastatic carcinoma using non-viable bacterial BCG formulation
- 2011 - 2013 Development of bladder cancer early diagnosis and treatment method using the CXCR4-beta arrestin2-ERK pathway
- 2009 - 2010 The analysis of host pathogen interaction in the intravesical BCG therapy
Show all